Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 50Infertility 21Anovulation 10Vitamin D Deficiency 2Rare Diseases 2Hyperinsulinism 2Hyperandrogenism 2Endocrine System Diseases 2Prolactinoma 1Primary Ovarian Insufficiency 1Pathologic Processes 1Motor Activity 1Leiomyoma 1Insulin Resistance 1Infertility, Female 1Hypogonadism 1Hyperprolactinemia 1

Interventions

Cabergoline 5Dopamine Agonists 2ropinirole 1pasireotide 1Temozolomide 1Surgical Procedures, Operative 1Standard of Care 1Microarray Analysis 1Lapatinib 1Early Intervention, Educational 1Dexamethasone 1DNA Methylation 1Clomiphene 1Calcium Dobesilate 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prolactinoma × Clomiphene × Clear all
NCT00697814 2008-06-16

Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Federal University of São Paulo

Phase 2 Completed
15 enrolled

Hypogonadism, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡